However, things become much more complicated if cancer has already metastasized. Metastasis occurs when circulating cancer cells break away from the original tumor, travel through the body via blood vessels and form new tumors in other organs.
To date, cancer research has not paid much attention to the question of when tumors shed metastatic cells. Researchers previously assumed that tumors release such cells continuously.
Circadian Rhythm-regulated Hormones Control Metastasis
“When the affected person is asleep, the tumor awakens,” summarises study leader Nicola Aceto, Professor of Molecular Oncology at ETH Zurich. During their study, which included 30 female cancer patients and mouse models, the researchers found that the tumor generates more circulating cells when the organism is asleep. Cells that leave the tumor at night also divide more quickly and therefore have a higher potential to form metastases compared to circulating cells that leave the tumor during the day.
Adjusting Therapies to the Tumor
In addition, the study indicates that the time in which tumor or blood samples are taken for diagnosis may influence the findings of oncologists. It was an accidental finding along these lines that first put the researchers on the right track, “Some of my colleagues work early in the morning or late in the evening; sometimes they’ll also analyze blood at unusual hours,” Aceto says with a smile. The scientists were surprised to find that samples taken at different times of the day had very different levels of circulating cancer cells.
Advertisement
Another clue was the surprisingly high number of cancer cells found per unit of blood in mice compared to humans. The reason was that as nocturnal animals, mice sleep during the day, which is when scientists collect most of their samples.
“In our view, these findings may indicate the need for healthcare professionals to systematically record the time at which they perform biopsies,” Aceto says. “It may help to make the data truly comparable.”
The researchers’ next step will be to figure out how these findings can be incorporated into existing cancer treatments to optimize therapies.
As part of further studies with patients, ETH Professor Nicola Aceto wants to investigate whether different types of cancer behave similarly to breast cancer and whether existing therapies can be made more successful if patients are treated at different times.
Source: Eurekalert
